Skip to main content

ePrognosis: What are the Next Steps

by: Alex Smith @alexsmithmd



We need your help.

We've come a long way with ePrognosis, our online and now mobile tool kit to estimate life expectancy in the elderly.  To quickly review:
  • Published systematic review of prognostic indices for older adults (JAMA link)
  • Launched ePrognosis in January 2012.
  • Over 1 million page views since launch, most from mobile devices
  • Launched mobile-friendly responsive web-design version of ePrognosis this summer (2013).  Responsive web design allows you to access ePrognosis from a web browser on any size device - a PC, laptop, tablet, or phone.  The website will automatically resize the browser window and the information in the window for the size of screen you are using.
  • ePrognosis users said the "bubbleview" home page was too complicated.  They just wanted to be quickly pointed to the best index for the patient in front of them.  We re-designed the landing page to be much simpler, asking easy questions that quickly take users to the highest quality index for the clinical situation at hand (e.g. a nursing home patient with dementia is taken immediatly to Susan Mitchell's index).
  • We launched ePrognosis: Cancer Screening - the app for iPhones and iPads - this week.  See more about the app in this post here.  Download the app here.
How can you help?  We need feedback from users!  What are we doing right? What can be better?  We welcome all feedback, from small fixes to big ideas.  Even if you're not a user - tell us why not?

With generous support from the John A Hartford Foundation, we are having a conference in January, 2014 to discuss Next Steps for ePrognosis.  We are open to the idea of inviting and funding a particularly enthusiastic and helpful user or users to join our conference in San Francisco. 

What are the next steps for ePrognosis?  Please respond in the comments!

Comments

Bruce Scott said…
You've come a long way, baby!

It's been a while since I've been here. I think I'll correct that error.

I look forward to test driving the mobile app.
Anonymous said…
Can the PiPS Prognosticator be incorporated?http://www.pips.sgul.ac.uk/index.htm

Popular posts from this blog

Dying without Dialysis

There is a terrific article in this weeks Journal of Pain and Symptom Management by Fliss Murtagh of King's College in London about the epidemiology of symptoms for patients with advanced renal failure who die without dialysis.  This study is important because while we know that patients with advanced renal failure have a limited life expectancy and the average age of initiation of hemodialysis is increasing, we know little about the alternatives to hemodialysis.  Specifically, we know nothing about symptoms affecting quality of life among patients who elect not to start dialysis (so called "conservative management" - is this the best label?).  This article provides a terrific counterpoint to the article in last years NEJM showing that nursing home residents who initiated hemodialysis tended to die and decline in function (see GeriPal write up here). 

The study authors followed patients with the most advanced form of chronic kidney disease (the new name for renal failu…

Language Matters: Podcast with Brian Block and Anna DeForest

One of our first GeriPal posts was titled "Rant on Terminology," by Patrice Villars, NP.  In the spirit of looking back over our first 10 years, here is the opening paragraph to that post:

News Headlines read: Sen. Edward Kennedy loses battle with cancer. Really, he lost? I thought he died from a malignant brain tumor, an “aggressive” brain tumor. The median survival is less than a year for people for his particular tumor. Kennedy was diagnosed in May of 2008. He lived over 15 months after diagnosis. What a loser. He must not have fought hard enough. Huh? I thought he spent most of his life battling for social and health care reform in America. In this week's GeriPal podcast we take a deeper dive into this issue of language and medicine.  We are joined by guests Anna DeForest, MD, MFA, a resident in Neurology at Yale, and Brian Block, MD, a pulmonary critical care fellow at UCSF.  

Anna recently published a paper in the NEJM describing her reaction to hearing terms like, &…

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …